x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:05:34

Tour of Scotland: Dundee based Glen Clova Scientific...

BiotechTV - News ·

2025/03/13

CEO Steven Powell joins BiotechTV from Scotland's Life Sciences Conference and Awards in Glasgow, and explains Glen Clova's expertise in making next generation VLPs. The first clinical program will be in senile pruritus, targeting IL-31.

en-us

00:07:20

Tour of Scotland: Mark Cook, Co-Chair of Life...

BiotechTV - News ·

2025/03/13

He describes the assets that Scotland has to offer the industry such as excellent universities that derive innovation and a diverse population that makes it a great region for clinical trials.

en-us

00:07:18

Tour of Scotland: Glasgow based Mironid is developing...

BiotechTV - News ·

2025/03/13

Co-Founder & CEO Neil Wilkie walks us through the biology of ADPKD and explains how Mironid is trying to uniquely directly target it. Plus, the growth of the company, investor support, and being based in Glasgow.

en-us

00:08:43

Tour of Scotland: Vicki Hazley, Associate Director of...

BiotechTV - News ·

2025/03/13

She describes The Bank's goal of supporting life sciences in Scotland and making a societal impact, how it aims to co-invest with likeminded investors. Plus, examples of investments such as Elasmogen and PneumoWave.

en-us

00:18:02

Professor Pieter Cullis and Jay Kulkarni, co-founders...

BiotechTV - News ·

2025/03/12

Professor Cullis, one of the original pioneers of LNPs and co-founder of 11 biotechnology companies, describes the challenge of successfully using lipid nanoparticles to deliver payloads to places outside of the liver. Jay Kulkarni, a former postdoc of his who is co-founder and CSO of the company, describes the 'one-stop-shop' capabilities of NanoVation, which has already led to a partnership with Novo Nordisk and others.

en-us

00:10:31

Tour of Scotland: Edinburgh based Trogenix is...

BiotechTV - News ·

2025/03/12

CEO Ken Macnamara describes the science behind this idea and discusses recently presented preclinical data. He highlights the lead program for glioblastoma and plans for the future, and also explains how he believes a patient sample biobank Trogenix has built is key to the company's success in research.

en-us

00:09:02

Tour of Scotland: A leading investor who is focused...

BiotechTV - News ·

2025/03/12

Andrew McNeill, Managing Partner of St. Andrews based Eos Advisory, introduces us to the firm and some portfolio companies including Dxcover and Laverock Therapeutics.

en-us

00:17:18

Acuitas Therapeutics is a pioneer in developing lipid...

BiotechTV - News ·

2025/03/12

Co-Founder & CEO Thomas Madden describes the science and history behind LNPs, and discusses what is currently in development, including trying to use them to deliver therapies outside of the liver.

en-us

00:09:32

Tour of Scotland: Edinburgh based Cumulus Oncology...

BiotechTV - News ·

2025/03/12

Founder & CEO Clare Wareing describes the company's design, with an eye towards being capital efficient and investing over and again for the long-term. She describes the lead investments: a PARG inhibitor, GPR68 small molecules, and a GTPase inhibitor.

en-us

00:07:59

Tour of Scotland: Outrun Therapeutics is aiming to...

BiotechTV - News ·

2025/03/12

CEO Carolyn Porter describes the beginning of the company, which spun out of University of Dundee's MRC Protein Phosphorylation and Ubiquitylation Unit (PPU). The first goal is to go after hard to treat solid tumors.

en-us

00:08:51

Tour of Scotland: Tay Therapeutics is a product of...

BiotechTV - News ·

2025/03/11

Founder and CEO Andrew Woodland describes how they made the decision to focus on inflammation for the pan-BET, which is partnered with VYNE Therapeutics. VYNE has also completed a phase 1a with Tay's oral selective BET inhibitor. Plus, how Tay is also working on a small molecule gene therapy program.

en-us

00:24:08

Tour of Scotland: University of Dundee has...

BiotechTV - News ·

2025/03/11

Founder and Director Alessio Ciulli explains the science behind protein degradation. He then describes the facilities that have been built and the work that takes place at the centre, including founding companies like Amphista Therapeutics. Plus, his take on the field more broadly and targets that researchers are going after.

en-us

00:05:14

Tour of Scotland: The Head of Business Development at...

BiotechTV - News ·

2025/03/11

Charlotte Green describes the work that the unit does in tropical diseases, CNS, women's health, and oncology. She also highlights their pharma partnerships and licenses, and cases where independent biotech companies have spun out of the work.

en-us

00:10:16

Tour of Scotland: Sir Michael Ferguson introduces the...

BiotechTV - News ·

2025/03/11

He discusses speciality work relating to molecular cell biology / signal transduction, and translational science. Plus, the MRC Protein Phosphorylation and Ubiquitylation Unit (PPU), the Drug Discovery Unit, the soon-to-open Innovation Hub, and more.

en-us

00:09:56

A study published in JMIR today showed that Limbic's...

BiotechTV - News ·

2025/03/10

Limbic CEO Ross Harper describes how patients who interacted with Limbic Care attended 42% more therapy sessions and achieved a 25% higher recovery rate compared to standard treatment.

en-us

00:35:55

Analyst Thursdays: William Blair Senior Analyst Andy...

BiotechTV - News ·

2025/03/06

He discusses what to look for in safety and efficacy, new targets, and his thoughts on the potential role of oral therapies. Plus, comments on Structure Therapeutics, Corbus, Skye Bioscience, Zealand, Viking, Altimmune, Terns, and BioAge Labs.

en-us

00:11:54

On Rare Disease Day, Ultragenyx's Head of Gene...

BiotechTV - News ·

2025/02/28

Matthew Fuller describes the course that Ultragenyx will be holding both in the Bay Area and Massachusetts. He also explains the improvements in vector delivery capabilities, and improving the yield and lowering the cost of future treatments, that is possible with the latest generation of gene therapy.

en-us

00:07:01

Cambridge, UK based Amphista Therapeutics is...

BiotechTV - News ·

2025/02/26

CEO Antony Mattessich describes the company's approach and the advantages he believes it has over other TPD. Plus, the lead program targeting BRD9, and how the company thinks about partnerships going forward.

en-us

00:07:12

Cambridge, UK based Ignota Labs raised a $6.9M seed...

BiotechTV - News ·

2025/02/26

Co-Founder and CEO Sam Windsor describes the rationale for using AI to focus more on tox, not efficacy, and gives and example of a drug the company has already in-licensed from a pharma company. Plus, what today's raise will enable the company to do.

en-us

00:14:41

With unique license agreements in place with local...

BiotechTV - News ·

2025/02/26

CEO Richard Mason describes the company's philosophy, and covers programs such as a FGF21/GLP-1 that was recently licensed from a Chinese partner, an IL18, ZIP12, and more.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter